Skip to content

Parecoxib-midazolam compared with fentanyl-midazolam as pain relief during transvaginal ultrasound controlled egg retrieval

Parecoxib-midazolam compared with fentanyl-midazolam as conscious sedation during transvaginal ultrasound controlled oocyte retrieval: a double-blind randomized trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN34698611
Enrollment
134
Registered
2022-06-06
Start date
2022-06-20
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women undergoing ultrasound controlled transvaginal oocyte retrieval for in vitro fertilisation Pregnancy and Childbirth

Interventions

1. Intravenous parecoxib 40 mg followed by IV midazolam 5 mg bolus 15 minutes before the procedure 2. Intravenous fentanyl 50 mcg followed by IV midazolam 5mg bolus 15 min prior to the

Sponsors

University Malaya Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women undergoing ovum pick up aged 18 to 45 years old 2. Suitable for conscious sedation

Exclusion criteria

Exclusion criteria: 1. Previous history of hypersensitivity or contraindication to midazolam/fentanyl/parecoxib 2. Women not suitable for conscious sedation OPU e.g., medical comorbidity such as hypertension on treatment, inflammatory bowel disease, ischemic heart disease and heart failure on anticoagulants, history of bronchospasm, history of cerebrovascular disease and upper GI perforation, severe hepatic impairment 3. Extreme anxiety 4. Anticipated complicated ovum pick up: extensive endometriosis, pelvic adhesions, difficult to access ovaries 5. Prior issues with conscious sedation

Design outcomes

Primary

MeasureTime frame
Successful sedation assessed using the Procedural Sedation Assessment Survey (PROSAS) at 30 minutes after awakening in the recovery area. “In accordance with patients’ priorities, procedural sedation was judged as successful when there was no adverse event, no issues with sedation leading to an incomplete procedure, when patient-reported procedural discomfort was scored 2 or less, and the patient was comfortable with the level of sedation obtained with a sedation preference score of between -2 and 2”

Secondary

MeasureTime frame
1. Pain measured using the numerical rating scale 0-10 at awakening, 15, 30, 45, 60 minutes and just before discharge 2. Nausea measured by asking Yes or No at awakening, 15, 30, 45, 60 minutes and just before discharge 3. Vomiting measured by asking Yes or No at awakening, 15, 30, 45, 60 minutes and just before discharge 4. Surgeon satisfaction with the sedation-pain relief during ovum pick up measured using the numerical rating scale after completing the oocyte retrieval procedure 5. Hypotension/hypertension (systolic blood pressure [SBP] 160 mmHg) measured using automated blood pressure during procedures and upon awakening, 15, 30, 45, 60 minutes and just before discharge 6. Tachycardia/bradycardia (heart rate > 120/min or < 50/min) measured using automated pulse oximetry during procedures and upon awakening, 15, 30, 45, 60 minutes and just before discharge 7. Oxygen desaturation (any episode of desaturation <90% on pulse oximetry) measured using automated pulse oximetry during procedures and upon awakening, 15, 30, 45, 60 minutes and just before discharge 8. Number of oocytes retrieved and charted using the standardised form provided in the Fertility Unit during the procedure, and the result will be obtained on completion of embryologist report

Countries

Malaysia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026